Cytotoxic T lymphocytes are particularly active during the acute phase of COVID-19, though it is not rare to observe a reduction in CD8+ T cells in severe cases of COVID-19 with a consequent neutrophilia [44]. The gene discussed is CD8A; the disease is COVID-19.